Desglucohellebrin

CAS : 20300-44-1

Ref. 3D-VAA30044

Informations sur le produit

• Nom: Desglucohellebrin
• Synonymes: Hellebrin, degluco-, Bufa-20,22-dienolide, 3-[(6-deoxy-α-L-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, (3β,5β)-, 5β-Bufa-20,22-dienolide, 3β-[(6-deoxy-α-L-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, (3β,5β)-3-[(6-Deoxy-α-L-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxobufa-20,22-dienolide, Deglucohellebrin

Description

Desglucohellebrin is a natural compound that has shown potential in the treatment of cancer. It is derived from Chinese medicinal herbs and has been found to be effective against human cancer cells. Desglucohellebrin works by inhibiting protein kinases, including cyclin-dependent kinases (CDKs), which are involved in cell cycle regulation. This inhibition leads to apoptosis, or programmed cell death, in cancer cells. Desglucohellebrin is an analog of hellebrin, a compound with known anticancer properties. The use of desglucohellebrin as a kinase inhibitor may have therapeutic implications for the treatment of various types of cancer.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 562.6 g/mol
• Formule: C₃₀H₄₂O₁₀
• Degré de pureté: Min. 95%